Early Amiodarone in Shockable Cardiac Arrest

Description

The primary objective of this pilot, pragmatic stepped-wedge cluster randomized trial is to evaluate if a modified cardiac arrest treatment algorithm calling for the administration of the initial amiodarone dose one 2-minute cycle earlier than current guidelines (during the same cycle as the initial dose of epinephrine) improves the time to amiodarone delivery in those with out-of-hospital cardiac arrest due to refractory ventricular fibrillation or ventricular tachycardia compared to usual care.

Conditions

Cardiac Arrest

Study Overview

Study Details

Study overview

The primary objective of this pilot, pragmatic stepped-wedge cluster randomized trial is to evaluate if a modified cardiac arrest treatment algorithm calling for the administration of the initial amiodarone dose one 2-minute cycle earlier than current guidelines (during the same cycle as the initial dose of epinephrine) improves the time to amiodarone delivery in those with out-of-hospital cardiac arrest due to refractory ventricular fibrillation or ventricular tachycardia compared to usual care.

Early Amiodarone in Shockable Cardiac Arrest (Early-Amio) Study

Early Amiodarone in Shockable Cardiac Arrest

Condition
Cardiac Arrest
Intervention / Treatment

-

Contacts and Locations

Portland

Oregon Health & Sciences University, Portland, Oregon, United States, 97035

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Emergency medical services (EMS)-treated non-traumatic out-of-hospital cardiac arrest
  • * Initial rhythm on EMS rhythm assessment of ventricular fibrillation or ventricular tachycardia
  • * Recurrence or persistence of ventricular fibrillation or ventricular tachycardia after one defibrillation attempt
  • * Known allergy to amiodarone
  • * EMS-assessed contraindication to amiodarone
  • * Pre-existing "do-not-attempt-resuscitation" orders
  • * Inter-facility transportations
  • * Initial care by a non-participating EMS agency able to perform advanced life support interventions
  • * Pediatric patient as determined by EMS
  • * Prisoners
  • * Pregnant patients

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Oregon Health and Science University,

Joshua Lupton, MD, MPH, PRINCIPAL_INVESTIGATOR, Oregon Health and Science University

Study Record Dates

2028-01-31